[1] Kok BH, Lim HT, Lim CP, Lai NS, Leow CY, Leow CH. Dengue virus infection - a review of pathogenesis, vaccines, diagnosis and therapy. Virus Res 2023;324:199018. https://doi.org/10.1016/j.virusres.2022.199018.
[2] Narayan R, Tripathi S. Intrinsic ADE: the dark side of antibody dependent enhancement during dengue infection. Front Cell Infect Microbiol 2020;10:580096. https://doi.org/10.3389/fcimb.2020.580096.
[3] Chinese center for disease control and prevention.Dengue Prevention and Control Plan(2025).https://www.chinacdc.cn/jkyj/crb2/yl/dgr/jswj_dgr/;2025 [2025-08-01].
[4] WHO. Dengue. 2025. https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue. [2025-6-1].
[5] Yue YJ, Liu QY, Liu XB, Zhao N, Yin WW. Dengue fever in mainland China, 2005-2020: a descriptive analysis of dengue cases and Aedes data. Int J Environ Res Public Health 2022;19(7):3910. https://doi.org/10.3390/ijerph19073910.
[6] Khetarpal N, Khanna I. Dengue fever: causes, complications, and vaccine strategies. J Immunol Res 2016;2016(1):6803098. https://doi.org/10.1155/2016/6803098.
[7] Harrison N, Burgmann H, Rabitsch W, Honsig C, Robak O. Influence of acute and chronic graft-versus-host disease on persistence of antibodies against measles, mumps, rubella and varicella in the first year after autologous or allogeneic hematopoietic stem cell transplantation. Vaccines (Basel) 2023;11(3):656. https://doi.org/10.3390/vaccines11030656.
[8] Allison M, Mathews J, Gilliland T, Mathew SO. Natural killer cell-mediated immunotherapy for leukemia. Cancers (Basel) 2022;14(3):843. https://doi.org/10.3390/cancers14030843.
[9] de Souza Pereira BB, Darrigo Junior LG, de Mello Costa TC, Felix AC, Simoes BP, Stracieri AB, et al. Prolonged viremia in dengue virus infection in hematopoietic stem cell transplant recipients and patients with hematological malignancies. Transpl Infect Dis 2017;19(4):e12721. https://doi.org/10.1111/tid.12721.
[10] Ng KH, Zhang SL, Tan HC, Kwek SS, Sessions OM, Chan CY, et al. Persistent dengue infection in an immunosuppressed patient reveals the roles of humoral and cellular immune responses in virus clearance. Cell Host Microbe 2019;26(5):601 − 5.e3. https://doi.org/10.1016/j.chom.2019.10.005.
[11] Thaivanich S, Visuthranukul J, Arunyingmongkol K, Bunworasate U, Siriyasatien P, Kulwichit W. Persistence of dengue genome in a remotely infected patient. Asian Biomed (Res Rev News) 2023;17(6):287 − 90. https://doi.org/10.2478/abm-2023-0072.
[12] Umakanth M, Suganthan N. Unusual manifestations of dengue fever: a review on expanded dengue syndrome. Cureus 2020;12(9):e10678. https://doi.org/10.7759/cureus.10678.